Imagin Medical Inc C.IME

Alternate Symbol(s): IMEXF

Imagin Medical Inc. is a urologic oncology company. It is engaged in developing technologies to better visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. Its first product, enCAGE Coil, is designed to eliminate the limitations of other methods of prostate cancer treatment that can cause erectile dysfunction and urinary incontinence. The device is a disposable, focal therapy, precision ablation system that will deliver bipolar, radio frequency energy through a distinctive coil electrode, or cage. It enables the surgeon to preset margins for precise tissue targeting. Its second product, the i/Blue Imaging System, will bring several key technological advancements that improve the utility of blue light imaging for visualizing bladder cancer. The i/Blue System delivers blue light imaging technology in a more versatile, practical, and accessible format and is designed to work with existing fiberoptic endoscopes on the market.

CSE:IME - Post by User

Imagin Medical Inc

Bullboard Posts

Comment by lessspikeon Jan 04, 2018 2:35am

182 Views

Post# 27277647

RE:Buyout after FDA approval of i/Blue system

While $1 does seem cheap based on the potential here, keep in mind there are 128 million shares fully diluted. Over 42 million warrants and options at under .20.

One acquisition in this space was just over $700 million. I doubt IME would go for that kind of price in 2018 (maybe in 2019 when most risks are off the table), but that would indicate a potential for $5+/share.